Resources Contact Us Home
Monoclonal antibody to CD166 and method for production thereof

Image Number 2 for United States Patent #8003762.

CD166 is a cell adhesion molecule belonging to an immunoglobulin superfamily that is expressed in an excessive amount on the tumor surface. If an monoclonal antibody specifically binding to the CD166 is obtained, it becomes possible to suppress growth of tumor cells, detect the cells, and supply a therapeutic drug thereto specifically. However, because the CD166 proteins are very similar to each other among mammals, it was not possible to obtain an antibody to human CD166, by immunizing, for example, mice with the human CD166. The antibody was prepared by immunizing mice with a purified avian CD166 protein. The antibody was found to be adsorbed on human and mouse CD166 proteins in vitro as well as in vivo and to have an action to suppress tumor growth in mice.

  Recently Added Patents
IC layout parsing for multiple masks
Eyeglass component
Clamp for fence panels
Network decoys
Catalyst composition with nanometer crystallites for slurry hydrocracking
Coffee cup stationery tab
System and methods for facilitating and documenting user thinking and learning using enhanced interactive constructs
  Randomly Featured Patents
Water-cooled panel for arc furnace
Process for preparing low-monomer-content TDI trimers
Optical see-through augmented reality modified-scale display
Tailgate for multiple compartment material container
Analyte monitoring device and methods of use
Performance of blasting caps
System for receiving and forming marketplaces for working on digital information blocks
Faucet handle
Exposure apparatus, exposure method and method for manufacturing devices
Shade positioning and mounting apparatus